Selected research
Market Structure
Global Kidney (Renal) Fibrosis Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Kidney (Renal) Fibrosis market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Kidney (Renal) Fibrosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Kidney (Renal) Fibrosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Kidney (Renal) Fibrosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Kidney (Renal) Fibrosis is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Kidney (Renal) Fibrosis include Merck, Roche, Pfizer, ProMetic Life-Sciences Inc., La Jolla Pharmaceutical Company, InterMune, Genzyme Corporation, Galectin Therapeutics and BioLine Rx Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Kidney (Renal) Fibrosis market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Kidney (Renal) Fibrosis and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Kidney (Renal) Fibrosis revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Kidney (Renal) Fibrosis market size, projected growth trends, production technologies, key applications, and end-use industries.
Kidney (Renal) Fibrosis Segment by Company
Merck
Roche
Pfizer
ProMetic Life-Sciences Inc.
La Jolla Pharmaceutical Company
InterMune
Genzyme Corporation
Galectin Therapeutics
BioLine Rx Ltd
Kidney (Renal) Fibrosis Segment by Type
Vasopeptidase Inhibitors
Angiotensin Converting enzyme (ACE) Inhibitors
Angiotensin II Receptor Blockers (ARBs)
Renin Inhibitors
Pirfenidone
Kidney (Renal) Fibrosis Segment by Application
Clinic
Hospital
Research Center
Kidney (Renal) Fibrosis Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Kidney (Renal) Fibrosis market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Kidney (Renal) Fibrosis and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Kidney (Renal) Fibrosis.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Kidney (Renal) Fibrosis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Kidney (Renal) Fibrosis industry.
Chapter 3: Detailed analysis of Kidney (Renal) Fibrosis companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Kidney (Renal) Fibrosisrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Vasopeptidase Inhibitors
- Angiotensin Converting enzyme (ACE) Inhibitors
- Angiotensin II Receptor Blockers (ARBs)
- Renin Inhibitors
- Pirfenidone
Applications
- Clinic
- Hospital
- Research Center
Companies covered
- Merck
- Roche
- Pfizer
- ProMetic Life-Sciences Inc.
- La Jolla Pharmaceutical Company
- InterMune
- Genzyme Corporation
- Galectin Therapeutics
- BioLine Rx Ltd
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Kidney (Renal) Fibrosis Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Vasopeptidase Inhibitors
- 1.2.3 Angiotensin Converting enzyme (ACE) Inhibitors
- 1.2.4 Angiotensin II Receptor Blockers (ARBs)
- 1.2.5 Renin Inhibitors
- 1.2.6 Pirfenidone
- 1.3 Market Analysis by Application
- 1.3.1 Global Kidney (Renal) Fibrosis Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Clinic
- 1.3.3 Hospital
- 1.3.4 Research Center
- 1.4 Global Market Growth Prospects
- 1.5 Global Kidney (Renal) Fibrosis Growth Trends by Region
- 1.5.1 Global Kidney (Renal) Fibrosis Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Kidney (Renal) Fibrosis Market Size by Region (2021-2026)
- 1.5.3 Kidney (Renal) Fibrosis Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Kidney (Renal) Fibrosis Market Dynamics
- 2.1 Kidney (Renal) Fibrosis Industry Trends
- 2.2 Kidney (Renal) Fibrosis Industry Drivers
- 2.3 Kidney (Renal) Fibrosis Industry Opportunities and Challenges
- 2.4 Kidney (Renal) Fibrosis Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Kidney (Renal) Fibrosis Revenue by Company (2021-2026)
- 3.2 Global Kidney (Renal) Fibrosis Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Kidney (Renal) Fibrosis Key Company Head office and Area Served
- 3.4 Global Kidney (Renal) Fibrosis Company, Product Type & Application
- 3.5 Global Kidney (Renal) Fibrosis Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Kidney (Renal) Fibrosis Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Kidney (Renal) Fibrosis Players Market Share by Revenue in 2025
- 3.6.3 2025 Kidney (Renal) Fibrosis Tier 1, Tier 2, and Tier 3
4 Kidney (Renal) Fibrosis Market by Type
- 4.1 Global Kidney (Renal) Fibrosis Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Kidney (Renal) Fibrosis Market Size by Type (2021-2032)
- 4.3 Global Kidney (Renal) Fibrosis Market Size Share by Type (2021-2032)
5 Kidney (Renal) Fibrosis Market by Application
- 5.1 Global Kidney (Renal) Fibrosis Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Kidney (Renal) Fibrosis Market Size by Application (2021-2032)
- 5.3 Global Kidney (Renal) Fibrosis Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Merck
- 6.1.1 Merck Company Information
- 6.1.2 Merck Business Overview
- 6.1.3 Merck Kidney (Renal) Fibrosis Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Merck Kidney (Renal) Fibrosis Product Portfolio
- 6.1.5 Merck Recent Developments
- 6.2 Roche
- 6.2.1 Roche Company Information
- 6.2.2 Roche Business Overview
- 6.2.3 Roche Kidney (Renal) Fibrosis Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Roche Kidney (Renal) Fibrosis Product Portfolio
- 6.2.5 Roche Recent Developments
- 6.3 Pfizer
- 6.3.1 Pfizer Company Information
- 6.3.2 Pfizer Business Overview
- 6.3.3 Pfizer Kidney (Renal) Fibrosis Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Pfizer Kidney (Renal) Fibrosis Product Portfolio
- 6.3.5 Pfizer Recent Developments
- 6.4 ProMetic Life-Sciences Inc.
- 6.4.1 ProMetic Life-Sciences Inc. Company Information
- 6.4.2 ProMetic Life-Sciences Inc. Business Overview
- 6.4.3 ProMetic Life-Sciences Inc. Kidney (Renal) Fibrosis Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 ProMetic Life-Sciences Inc. Kidney (Renal) Fibrosis Product Portfolio
- 6.4.5 ProMetic Life-Sciences Inc. Recent Developments
- 6.5 La Jolla Pharmaceutical Company
- 6.5.1 La Jolla Pharmaceutical Company Company Information
- 6.5.2 La Jolla Pharmaceutical Company Business Overview
- 6.5.3 La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 La Jolla Pharmaceutical Company Kidney (Renal) Fibrosis Product Portfolio
- 6.5.5 La Jolla Pharmaceutical Company Recent Developments
- 6.6 InterMune
- 6.6.1 InterMune Company Information
- 6.6.2 InterMune Business Overview
- 6.6.3 InterMune Kidney (Renal) Fibrosis Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 InterMune Kidney (Renal) Fibrosis Product Portfolio
- 6.6.5 InterMune Recent Developments
- 6.7 Genzyme Corporation
- 6.7.1 Genzyme Corporation Company Information
- 6.7.2 Genzyme Corporation Business Overview
- 6.7.3 Genzyme Corporation Kidney (Renal) Fibrosis Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Genzyme Corporation Kidney (Renal) Fibrosis Product Portfolio
- 6.7.5 Genzyme Corporation Recent Developments
- 6.8 Galectin Therapeutics
- 6.8.1 Galectin Therapeutics Company Information
- 6.8.2 Galectin Therapeutics Business Overview
- 6.8.3 Galectin Therapeutics Kidney (Renal) Fibrosis Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Galectin Therapeutics Kidney (Renal) Fibrosis Product Portfolio
- 6.8.5 Galectin Therapeutics Recent Developments
- 6.9 BioLine Rx Ltd
- 6.9.1 BioLine Rx Ltd Company Information
- 6.9.2 BioLine Rx Ltd Business Overview
- 6.9.3 BioLine Rx Ltd Kidney (Renal) Fibrosis Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 BioLine Rx Ltd Kidney (Renal) Fibrosis Product Portfolio
- 6.9.5 BioLine Rx Ltd Recent Developments
7 North America
- 7.1 North America Kidney (Renal) Fibrosis Market Size (2021-2032)
- 7.2 North America Kidney (Renal) Fibrosis Market Size by Type
- 7.2.1 North America Kidney (Renal) Fibrosis Market Size by Type (2021-2026)
- 7.2.2 North America Kidney (Renal) Fibrosis Market Size by Type (2027-2032)
- 7.2.3 North America Kidney (Renal) Fibrosis Market Share by Type (2021-2032)
- 7.3 North America Kidney (Renal) Fibrosis Market Size by Application
- 7.3.1 North America Kidney (Renal) Fibrosis Market Size by Application (2021-2026)
- 7.3.2 North America Kidney (Renal) Fibrosis Market Size by Application (2027-2032)
- 7.3.3 North America Kidney (Renal) Fibrosis Market Share by Application (2021-2032)
- 7.4 North America Kidney (Renal) Fibrosis Market Size by Country
- 7.4.1 North America Kidney (Renal) Fibrosis Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Kidney (Renal) Fibrosis Market Size by Country (2021-2026)
- 7.4.3 North America Kidney (Renal) Fibrosis Market Size by Country (2027-2032)
- 7.4.4 North America Kidney (Renal) Fibrosis Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Kidney (Renal) Fibrosis Market Size (2021-2032)
- 8.2 Europe Kidney (Renal) Fibrosis Market Size by Type
- 8.2.1 Europe Kidney (Renal) Fibrosis Market Size by Type (2021-2026)
- 8.2.2 Europe Kidney (Renal) Fibrosis Market Size by Type (2027-2032)
- 8.2.3 Europe Kidney (Renal) Fibrosis Market Share by Type (2021-2032)
- 8.3 Europe Kidney (Renal) Fibrosis Market Size by Application
- 8.3.1 Europe Kidney (Renal) Fibrosis Market Size by Application (2021-2026)
- 8.3.2 Europe Kidney (Renal) Fibrosis Market Size by Application (2027-2032)
- 8.3.3 Europe Kidney (Renal) Fibrosis Market Share by Application (2021-2032)
- 8.4 Europe Kidney (Renal) Fibrosis Market Size by Country
- 8.4.1 Europe Kidney (Renal) Fibrosis Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Kidney (Renal) Fibrosis Market Size by Country (2021-2026)
- 8.4.3 Europe Kidney (Renal) Fibrosis Market Size by Country (2027-2032)
- 8.4.4 Europe Kidney (Renal) Fibrosis Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Kidney (Renal) Fibrosis Market Size (2021-2032)
- 9.2 China Kidney (Renal) Fibrosis Market Size by Type
- 9.2.1 China Kidney (Renal) Fibrosis Market Size by Type (2021-2026)
- 9.2.2 China Kidney (Renal) Fibrosis Market Size by Type (2027-2032)
- 9.2.3 China Kidney (Renal) Fibrosis Market Share by Type (2021-2032)
- 9.3 China Kidney (Renal) Fibrosis Market Size by Application
- 9.3.1 China Kidney (Renal) Fibrosis Market Size by Application (2021-2026)
- 9.3.2 China Kidney (Renal) Fibrosis Market Size by Application (2027-2032)
- 9.3.3 China Kidney (Renal) Fibrosis Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Kidney (Renal) Fibrosis Market Size (2021-2032)
- 10.2 Asia Kidney (Renal) Fibrosis Market Size by Type
- 10.2.1 Asia Kidney (Renal) Fibrosis Market Size by Type (2021-2026)
- 10.2.2 Asia Kidney (Renal) Fibrosis Market Size by Type (2027-2032)
- 10.2.3 Asia Kidney (Renal) Fibrosis Market Share by Type (2021-2032)
- 10.3 Asia Kidney (Renal) Fibrosis Market Size by Application
- 10.3.1 Asia Kidney (Renal) Fibrosis Market Size by Application (2021-2026)
- 10.3.2 Asia Kidney (Renal) Fibrosis Market Size by Application (2027-2032)
- 10.3.3 Asia Kidney (Renal) Fibrosis Market Share by Application (2021-2032)
- 10.4 Asia Kidney (Renal) Fibrosis Market Size by Country
- 10.4.1 Asia Kidney (Renal) Fibrosis Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Kidney (Renal) Fibrosis Market Size by Country (2021-2026)
- 10.4.3 Asia Kidney (Renal) Fibrosis Market Size by Country (2027-2032)
- 10.4.4 Asia Kidney (Renal) Fibrosis Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Kidney (Renal) Fibrosis Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Kidney (Renal) Fibrosis Market Size by Type
- 11.2.1 South America, Middle East & Africa Kidney (Renal) Fibrosis Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Kidney (Renal) Fibrosis Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Kidney (Renal) Fibrosis Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Kidney (Renal) Fibrosis Market Size by Application
- 11.3.1 South America, Middle East & Africa Kidney (Renal) Fibrosis Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Kidney (Renal) Fibrosis Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Kidney (Renal) Fibrosis Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Kidney (Renal) Fibrosis Market Size by Country
- 11.4.1 South America, Middle East & Africa Kidney (Renal) Fibrosis Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Kidney (Renal) Fibrosis Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Kidney (Renal) Fibrosis Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Kidney (Renal) Fibrosis Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst